Crossref
Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
Liver International · 2026-12 · 46 (12)
DOI: 10.1111/liv.70946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 20.11.2026. Verfasst von Yitong He und 2 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
He, Y., Liu, T., & Song, H. (2026). Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab. Liver International, 46(12). https://doi.org/10.1111/liv.70946
Vancouver
He Y, Liu T, Song H. Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab. Liver International. 2026;46(12). doi:10.1111/liv.70946
BibTeX
@article{He2026,
author = {He, Yitong and Liu, Tao and Song, Haiyan},
title = {Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab},
journal = {Liver International},
year = {2026},
volume = {46},
number = {12},
doi = {10.1111/liv.70946}
}
EUVIMED